Peripheral Arterial Disease Trial, Recruiting NCT06300450 Sponsor: Brigham and Women's Hospital Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06300450
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are seen at a clinic for heart and blood vessel care, general/primary care, foot care, vascular surgery, or diabetes management
  • You have a diagnosis of PAD (peripheral artery disease, a condition affecting blood flow in the arteries) recorded in your medical history
  • You are not currently taking any medication prescribed to lower your LDL cholesterol (often called "bad" cholesterol)

Who may not be able to join:

  • You are currently taking any medication used to lower LDL cholesterol, including statins (such as atorvastatin or rosuvastatin), ezetimibe, bempedoic acid, PCSK9 inhibitors, inclisiran, or any combination of these types of drugs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gregory Piazza, BWH

Phone: 6177326984

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
28 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Frequency of prescription of oral LDL-C-lowering therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov